Using machine learning framework to identify prognostic biomarkers in neuroblastoma Post author:admin Post published: August 11, 2025 Post category:uncategorized Neuroblastoma is the most common solid tumor in infants and accounts for nearly 15% of all pediatric cancer-related deaths. You Might Also Like New AI tool could revolutionize clinical trial efficiency and cost June 17, 2024 New scoring system enhances identification of HFpEF patients July 29, 2024 AI model diagnoses lung cancer using just a laptop June 5, 2025